Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

325.64
+0.36000.11%
Post-market: 325.640.00000.00%16:41 EDT
Volume:912.19K
Turnover:297.60M
Market Cap:42.46B
PE:-155.20
High:329.34
Open:325.28
Low:322.30
Close:325.28
Loading ...

Alnylam Stock Jumps After the FDA Approves Its Heart Drug -- WSJ

Dow Jones
·
22 Mar

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy

Zacks
·
22 Mar

BUZZ-U.S. STOCKS ON THE MOVE-ACNB, Carnival Corp, Boeing

Reuters
·
21 Mar

BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue?

Zacks
·
21 Mar

Alnylam Pharmaceuticals Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
21 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Microchip Technology, IAC, Micron Technology

Reuters
·
21 Mar

Sector Update: Health Care Stocks Steady Premarket Friday

MT Newswires Live
·
21 Mar

RBC Adjusts Price Target on Alnylam Pharmaceuticals to $330 From $310, Maintains Outperform Rating

MT Newswires Live
·
21 Mar

Alnylam Pharma (ALNY) Initiated with a Hold at Cantor Fitzgerald

TIPRANKS
·
21 Mar

Alnylam Pharma (ALNY) Gets a Buy from Chardan Capital

TIPRANKS
·
21 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Cowell, Nike, Alnylam Pharma

Reuters
·
21 Mar

Alnylam's Amvuttra Seen as Mega Blockbuster -- Market Talk

Dow Jones
·
21 Mar

Alnylam shares rise on expanded heart drug approval

Reuters
·
21 Mar

Alnylam Pharmaceuticals Price Target Maintained With a $320.00/Share by Needham

Dow Jones
·
21 Mar

BUZZ-Alnylam zooms as FDA expands approval of rare heart disease drug

Reuters
·
21 Mar

Alnylam Pharmaceuticals Recieives US FDA Approval for ATTR-CM Drug

MT Newswires Live
·
21 Mar

Barclays Keeps Their Buy Rating on Alnylam Pharma (ALNY)

TIPRANKS
·
21 Mar

U.S. RESEARCH ROUNDUP-Darden Restaurants, Nike, Optinose

Reuters
·
21 Mar

Alnylam's Amvuttra Gets Approval for Expanded Indication From FDA

Dow Jones
·
21 Mar

Alnylam’s Amvuttra approved by FDA in cardiomyopathy

TIPRANKS
·
21 Mar